The association of infection of the Clostridium difficile with occurrence of pseudomembranous colitis in a regional hospital;Asociace infekce Clostridium difficile a pseudomembranózní kolitidy v nemocnici okresního typu

Vnitrni Lekarstvi

Volumn 49, Issue 8, 2003, Pages 645-649

  Zemanová, Eva ^a   Urban, O ^a   Chalupa, J ^a   Mrozek V ^a   Taubova V ^a  

^a ORL Oddeleni Nemocnice Frydku Mistku   (Czech Republic)

Author keywords

Clostridium difficile; Nosocomial infection; Pseudomembranous colitis

Indexed keywords

BETA LACTAMASE; CEPHALOSPORIN DERIVATIVE; ENTEROTOXIN;

ADULT; ANAEROBIC BACTERIUM; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM DETECTION; CLINICAL ARTICLE; CLOSTRIDIUM DIFFICILE; DISEASE ASSOCIATION; ENZYME ACTIVITY; FEMALE; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; MALE; MORTALITY; PSEUDOMEMBRANOUS COLITIS; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; CZECH REPUBLIC; ENTEROCOLITIS, PSEUDOMEMBRANOUS; HOSPITALS, DISTRICT; HUMANS; MIDDLE AGED;

EID: 0041817724     PISSN: 0042773X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Auvray, L., Lenfant, F., Lenfant, L. et al.: Recurrent fatal pseudomembranous colitis. Presse Med., 2001, 30 (28), 1399-1400
2. Barbut, F., Lalande, V., Burghoffer, B. et al.: Prevalence and genetic characterization of toxin A variant strains of Clostridium difficile among adults and children with diarrhea in France. J. Clin. Microbiol. (United States), 2002, 40 (6), 2079-2083
3. Barbut, F., Petit, J. C.: Epidemiology, risk factors and prevention of Clostridium difficile nosocomial infections. Pathol. Biol. (Paris) (France), 2000, 48 (8), 745-755
4. Barbut, F., Richard, A., Hamadi, K. et al.: Epidemiology of recurrences or reinfections of Clostridium difficile-associated diarrhea. J. Clin. Microbiol. (United States), 2000, 38 (6), 2386-2388
5. Dallal, R. M., Harbrecht, B. G., Boujoukas, A. J. et al.: Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications. Ann. Surg. (United States), 2002, 235 (3), 363-372
6. D'Souza, A. L., Rajkumar, C., Cooke, J. et al.: Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis. BMJ, (England), 2002, 324 (7350), 1361
7. Fawley, W. N., Wilcox, M. H.: Molecular epidemiology of endemic Clostridium difficile infection. Epidemiol. Infect. (England), 2001, 126 (3), 343-350
8. Fekety, R.: ACG Treatment guideline: C.difficile-associated diarrhea and colitis. American Journal of Gastroenterology, 1997, 5, 92
9. Fernandez-Canigia, L., Nazar, J., Arce, M. et al.: Clostridium difficile diarrhea: frequency of detection in a medical center in Buenos Aires, Argentina. Rev. Argent. Microbiol. (Argentina), 2001, 33 (2), 101-107
10. Grunewald, T., Frenzel, S., Decker, M. et al.: Nosocomial epidemiology and transmission of Clostridium difficile infection. Dtsch. Med. Wochenschr. (Germany), 2001, 126 (18), 519-522
11. Kuijper, E. J., de Weerdt, J., Kato, H. et al.: Nosocomial outbreak of Clostridium difficile-associated diarrhoea due to a clindamycin-resistant enterotoxin A-negative strain. Eur. J. Clin. Microbiol. Infect. Dis. (Germany), 2001, 20 (8), 528-534
12. Kyne, L., Farrell, R. J., Kelly, C. P.: Clostridium difficile. Gastroenterol. Clin. North. Am. (United States), 2001, 30 (3), 753-777
13. Kyne, L., Warny, M., Qamar, A. et al.: Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. N. Engl. J. Med. (United States), 10, 2000, 342 (6), 390-397
14. Lozniewski, A., Rabaud, C., Dotto, E. et al.: Laboratory diagnosis of Clostridium difficile-associated diarrhea and colitis: usefulness of Premier Cytoclone A+B enzyme immunoassay for combined detection of stool toxins and toxigenic C. difficile strains. J. Clin. Microbiol. (United States), 2001, 39 (5), 1996-1998
15. O'Connor, D., Hynes, P., Cormican, M. et al.: Evaluation of methods for detection of toxins in specimens of feces submitted for diagnosis of Clostridium difficile-associated diarrhea. J. Clin. Microbiol. (United States), 2001, 39 (8), 2846-2849
16. Oguz, F., Uysal, G., Dasdemir, S. et al.: The role of Clostridium difficile in childhood nosocomial diarrhea. Scand. J. Infect. Dis. (Sweden), 2001, 33 (10), 731-733
17. Pedersen, F., Lester, A., Petersen, H. D.: Diagnosis of Clostridium difficile infection in pseudomembranous colitis. Ugeskr Laeger (Denmark), 29, 2000, 162 (22), 3200-3201
18. Pituch, H., van den Braak, N., van Leeuwen, W. et al.: Clonal dissemination of a toxin-A-negative/toxin-B-positive Clostridium difficile strain from patients with antibiotic-associated diarrhea in Poland. Clin. Microbiol. Infect. (France), 2001, 7 (8), 442-446
19. Shek, F. W., Stacey, B. S., Rendell, J. et al.: The rise of Clostridium difficile: the effect of length of stay, patient age and antibiotic use. J. Hosp. Infect. (England), 2000, 45 (3), 235-237
20. Strus, M., Pakosz, K., Gosciniak, H. et al.: Antagonistic activity of Lactobacillus bacteria strains against anaerobic gastrointestinal tract pathogens (Helicobacter pylori, Campylobacter coli, Campylobacter jejuni, Clostridium difficile). Med. Dosw. Mikrobiol. 2001, 53 (2), 133-142
21. Svenungsson, B., Lagergren, A., Lundberg, A.: Clostridium difficile cytotoxin B in adults with diarrhea: a comparison of patients treated or not treated with antibiotics prior to infection. Clin. Microbiol. Infect. (France), 2001, 7 (8), 447-450
22. Schwaber, M. J., Simhon, A., Block, C. et al.: Factors associated with nosocomial diarrhea and Clostridium difficile-associated disease on the adult wards of an urban tertiary care hospital. Eur. J. Clin. Microbiol. Infect. Dis. (Germany), 2000, 19 (1), 9-15
23. Wilcox, M. H., Fawley, W. N.: Hospital desinfectants and spore formation by Clostridium difficile. Lancet (England), 14, 2000, 356 (9238), 1324
24. Zbořil, V.: Fyziologie mikroflory trávicího traktu. Vnitř. Lék., 48, 2002, 1, 17-21